Welcome to Immunitor Corporation

Immunitor Co.
Immunitor Co. Logo
Immunitor web site - navigation.html Immunitor - About Us

About Us

Immunitor Corporation Co., Ltd., is the first private biotech company formed in Thailand

Immunitor - Technology Platform

Technology Platform

Technology developed by Immunitor allows to formulate any desired immunogen or antigen as an oral tablet.

Such antigens are formulated into an ordinary appearing pill in such a way that they can withstand the digestive degradation in the stomach but are capable to trigger immune response once presented by the intestinal cells. These antigens are designed to induce the mucosal immune response as a means to treat, control or prevent disease. Any type of disease which requires mucosal immune control, such as infectious and autoimmune diseases and cancer are potential candidates for this technology. .

Immunitor - Products

Products

The first and most advanced product is V-1 Immunitor or V1. V1 has been used by over 60,000 AIDS patients in Thailand and 7,000 patients in 60 countries around the world. Approximately 12 mln doses of V1 have been manufactured to date. In addition to V1 the company has developed and currently manufactures V2, V3, and V4, which are used for treatment and prevention of diarrhea, Strep/Staph infection, cancer, and fungal infections.

Immunitor - Pipeline

Pipeline

Immunitor in collaboration with strategic partners has initiated development of several oral vaccines, e.g., hepatitis, SARS, and smallpox. Other vaccines to address global health problems such as malaria and TB are being planned.

Immunitor - Clinical Trials

Clinical Trials

Phase II clinical trials of V1 as prophylactic and therapeutic modalities have been completed. The results of V1 trial as a prophylactic vaccine have been published in VACCINE journal. The results of V1 as AIDS therapy will be published in 2004. The company is now preparing to initiate the pivotal phase III trial to file NDA or BLA as a therapeutic AIDS vaccine.

Immunitor - Contact Immunitor - News

News

News about Immunitor will be updated periodically here

Immunitor - Press Releases

Press Releases

Company press releases will be updated here.

Contact

Contact us at:

Immunitor Corporation Co., Ltd., 71 Moo 5, Bangpakong Industrial Park, Takarm, Chachoengsao 24130, Thailand Tel: 66-9-244-6398; Fax: 1-775-640-6636; E-mail: info@immunitor.com